BioAdaptives BDPT Stock
BioAdaptives Price Chart
BioAdaptives BDPT Financial and Trading Overview
| BioAdaptives stock price | 0.0060 USD |
| Previous Close | 0.01 USD |
| Open | 0.01 USD |
| Bid | 0.0085 USD x 16000000 |
| Ask | 0.0088 USD x 2211600 |
| Day's Range | 0.009 - 0.01 USD |
| 52 Week Range | 0.0081 - 0.09 USD |
| Volume | 72.43K USD |
| Avg. Volume | 20.78K USD |
| Market Cap | 108.08K USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.14 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
BDPT Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
BioAdaptives Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -87.40% |
| S&P500 52-Week Change | 27.29% |
| 52 Week High | 0.09 USD |
| 52 Week Low | 0.0081 USD |
| 50-Day Moving Average | 0.01 USD |
| 200-Day Moving Average | 0.02 USD |
BDPT Share Statistics
| Avg. Volume (3 month) | 20.78K USD |
| Avg. Daily Volume (10-Days) | 16.83K USD |
| Shares Outstanding | 12.01M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 0.14% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | 0.002 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -0.14 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | -0.177 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of BioAdaptives
| Country | United States |
| State | NV |
| City | Las Vegas |
| Address | 2620 Regatta Drive |
| ZIP | 89128 |
| Phone | 702 659 8829 |
| Website | https://www.shopbioadaptives.com |
| Industry | Packaged Foods |
| Sector(s) | Consumer Defensive |
| Full Time Employees | 1 |
BioAdaptives, Inc. investigates, markets, and distributes natural plant, fungi, and algal-based products and medical devices for humans and animals. The company offers MyndMed for immediate cognitive enhancement, medium-term resilience and memory gains, and long-term neuroprotection and cognitive health; Zeranovia, a weight loss enhancer; Wynovia to help reduce the loss of lean muscle mass during dieting; and Xcellara, a regenerative wellness solution. It also provides canine products under the PawPa brand; dog chew products under the Regen brand; and Lung Flute, a medical device. The company was formerly known as APEX 8 Inc. and changed its name to BioAdaptives, Inc. in September 2013. BioAdaptives, Inc. was incorporated in 2013 and is based in Las Vegas, Nevada.
Q&A For BioAdaptives Stock
What is a current BDPT stock price?
BioAdaptives BDPT stock price today per share is 0.0060 USD.
How to purchase BioAdaptives stock?
You can buy BDPT shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for BioAdaptives?
The stock symbol or ticker of BioAdaptives is BDPT.
Which industry does the BioAdaptives company belong to?
The BioAdaptives industry is Packaged Foods.
How many shares does BioAdaptives have in circulation?
The max supply of BioAdaptives shares is 12.01M.
What is BioAdaptives Price to Earnings Ratio (PE Ratio)?
BioAdaptives PE Ratio is now.
What was BioAdaptives earnings per share over the trailing 12 months (TTM)?
BioAdaptives EPS is -0.14 USD over the trailing 12 months.
Which sector does the BioAdaptives company belong to?
The BioAdaptives sector is Consumer Defensive.